S J van Zanten. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Anti-Bacterial Agents/economicsAnti-Bacterial Agents/therapeutic useCost-Benefit AnalysisDyspepsia/drug therapyDyspepsia/microbiologyHelicobacter Infections/complicationsHelicobacter Infections/drug therapyHelicobacter pyloriHumansMeta-Analysis as Topic
Substances: See more » Anti-Bacterial Agents
Year: 2000 PMID: 10987749 PMCID: PMC1118538 DOI: 10.1136/bmj.321.7262.648
Source DB: PubMed Journal: BMJ ISSN: 0959-8138